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in secondary spongious zone and diaphyseal cortical bone and
slightly in primary spongious area, and iii) bone microarchitecture
showed higher values of BV/TV, Tb.th, Tb.N and lower value of
Tb.Spin treated rats. Finally, we demonstrated that the overproduc-
tion of RANKL and IL-17 in sera of arthritic animals was prevented
by pioglitazone treatment.
Conclusions: In the present study, we demonstrated that pi-
oglitazone had bone protective properties in arthritis-induced in-
ﬂammation. The concomitant decrease of circulating IL-17 and
RANKL levels strongly suggests that pioglitazone anti-resorptive
effect is likely supported by the modulation of the IL-17-RANKL
osteoclastogenesis pathway.
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DEVELOPMENT OF A HUMAN OSTEOCLAST SYSTEM FOR
THE ASSESSMENT OF OSTEOCLAST ACTIVITIES AND
PHENOTYPES IN OSTEOARTHRITIS
K. Herniksen, M.G. Soerensen, C. Crüger-Hansen,
A.V. Neutzsky-Wullf, D. Kocijancic, D.J. Leeming,
A.-C. Bay-Jensen, M.A. Karsdal
Nordic BioSci. A/S, Herlev, Denmark
Purpose: Studies of animal models of osteoarthritis undergoing
anti-resorptive therapy have suggested that inactivation of bone re-
sorption leads to improved articular cartilage status. However, the
role of osteoclasts, and subchondral bone turnover, still remains
to be elucidated. In alignment, an increasing amount of research
is devoted to the cellular phenotype associated with disease sta-
tus. The osteoclast phenotype associated with osteoarthritis has
not been investigated. We developed a pure human osteoclast
system, and investigated the cellular phenotype on various bone
substrates; cortical, trabecular and calcitﬁed cartilage.
Methods: CD14+ monocytes were isolated from human peripheral
blood using a ﬁcoll gradient and magnetic sorting. For investigation
of osteoclastogenesis the CD14+ cells were seeded on either
cortical bovine bone slices or plastic with 25ng/mL RANKL and M-
CSF in the presence or absence of 17β-estradiol (0.001-10nM) and
cultured for 21 days. For mature human osteoclast experiments
CD14+ cells were cultured in ﬂasks for 10 days, and the lifted and
reseeded onto different matrices and cultured for another 10 days
in the presence or absence of well-characterized bone resorption
inhibitors (calcitonin (1nM-1μM), ibandronate (1μM) and diphyllin
(300nM)). Osteoclastogenesis was assayed using the osteoclast
marker Tartrate Resistant Acid Phosphatase (TRACP), as well
as TRACP staining. Bone resorption was assayed by calcium
release and CTX-I (C-terminal Telopeptide of Type I Collagen) all in
cell culture supernatants. Immunocytochemistry for the calcitonin
receptor (CTR) and TRACP was performed on both precursors
and mature osteoclasts on bone. Finally, mature osteoclasts were
seeded on calciﬁed cartilage from bovine knee joints, human
trabecular bone from vertebrae and human cortical bone from
femurs in the presence or absence of resorption inhibitors.
Results: Osteoclastogenesis was clearly seen when measuring
TRACP, CTX-I and calcium release, with TRACP release initiated
on day 5 of culture and CTX-I and calcium release on day 7.
All markers were increased more than 500% (P<0.01), compared
to initial values. TRACP staining conﬁrmed the presence of large
multinucleated TRACP positive cells. For the mature human os-
teoclasts intense bone resorption was observed within 24 hours
after seeding on bovine bone slices, and bone resorption was
attenuated by more than 70% in the presence of the resorption
inhibitors (P<0.01). Immunocytochemistry for CTR and TRACP
clearly demonstrated the presence of mature osteoclasts. Inter-
estingly human osteoclasts also resorbed the calciﬁed cartilage,
the human trabecular and cortical bones, although differences
in the level of resorption were observed, suggesting an induc-
tion of distinct osteoclast phenotypes that is dependent on the
extracellular matrix at which they are activated.
Conclusions: We have demonstrated that CD14+ monocytes iso-
lated from human peripheral blood are a highly useful source of
osteoclasts, which are characterized by expression of the CTR,
TRACP and bone resorption, all which are hallmarks of osteo-
clast function. We used this high quality osteoclast preparation to
demonstrate that osteoclasts resorb calciﬁed cartilage, and since
this process is involved in the pathogenesis of OA this system
can be used for characterizing osteoclast related effects on joint
turnover.
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Purpose: We have reported that the impairment of osteoclast
fusion had important roles for the delayed fracture healing in
streptozotocin (STZ)-induced diabetic mice. In this study, we fur-
ther investigated the mechanism of the malfunction of diabetic
osteoclasts using genetic analysis in vivo and cell culture in vitro.
Methods: The C57BL/6 mice were irradiated (9 Gy) and injected
with 4 × 106 bone marrow cells isolated from C57BL/6-EGFP
mice. The diabetes was induced by intravenous administration of
STZ (150 mg·kg-1 in mice). The control was injected with sodium
citrate buffer. At 6 weeks after transfer, bone marrow cells were
isolated from both the STZ and control groups, and then cultured
in the 96well dish with the cortical bone plate. The cortical bone
plates were extraction skull bones of wild type C57BL/6, and those
were ﬁxed and dehydrated with 100% ethanol. The cell culture was
performed in DMEM supplemented with 10% fetal bovine serum
under 5% CO2 and 95% air at 37 °C, and the ﬂoating cell was
removed after 2 h incubation. On day 3, 5, and 7, the cortical bone
plates were examined to analyze the formation of the resorption
pits by a scanning electron microscope.
The standardized closed fracture models were created in both the
control and STZ group. At 2 weeks after the fracture, the frozen
sections of the fracture site were created. The osteoclasts at
callus area were captured by laser capture microdissection (LCM).
We extracted RNA and synthesized cDNA by using commercial
kit. RT-PCR was performed to evaluate the mRNA expressions
of MMP9, Catepsin-K, Receptor activator of NF-kappaB (RANK),
dendritic cell-speciﬁc transmembrane protein (DC-STAMP), and
GAPDH.
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Results: The resorption pits made by osteoclasts were well
demonstrated on the cortical bone plates. The area of the re-
sorption pits became larger sequentially on day 3, 5, and 7
in osteoclast-cell culture. In the STZ group, the resorption-pit
area was signiﬁcantly decreased compared with that in control
group. The expression levels of MMP9, Catepsin-K, and RANK
showed no difference in between control and STZ group. On the
other hand, expression levels of DC-STAMP were signiﬁcantly
decreased in STZ group.
Conclusions: In the last meeting, we reported that the osteoclast
fusion was impaired, the cartilage resorption was decreased,
and the endocondral ossiﬁcation was delayed in the STZ-induced
diabetic mice. In this study, we found that the impaired bone
resorption in STZ might be produced by a decreased expression
of DC-STAMP in osteoclasts. Since DC-STAMP has a central role
for the formation of multinuclear osteoclasts, our result indicates
that the up-regulation of DC-STAMP may be useful to prevent
osteopenia in diabetes mellitus.
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COMPRESSION INDUCES THE EXPRESSION OF A
SCLEROTIC PHENOTYPE IN HUMAN SUBCHONDRAL
OSTEOBLASTS
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Purpose: Recent data showed that subchondral bone plays an
important role in osteoarthritis (OA). Metabolic and morphologic
modiﬁcations in this tissue contribute to the degradation of the
overlaying cartilage. It was suggested that abnormal mechani-
cal pressure applied to the articulation was responsible to these
changes. Here, we evaluated the effects of compression on os-
teoblasts from subchondral bone.
Methods: Osteoblasts were isolated from sclerotic (SC) or non-
sclerotic (NSC) areas of human OA subchondral bone. After 28
days, osteoblasts were surrounded by a newly synthesized ma-
trix and formed a strong membrane. This osteoblasts-containing
membrane was then placed onto a Biopress Flexercell plate and
submitted to compression (1.67 MPa) for 4 hours at the frequency
of 1 Hz. The expression of IL-6, IL-8, COX-2, VEGF, IGF-1, OPG
and RANKL was evaluated by RT-PCR. IL-6, IL-8 and PGE2 were
quantiﬁed by ELISA.
Results: Basal IL-6, VEGF, COX-2, IGF-1 and RANKL mRNA
levels were signiﬁcantly increased in SC osteoblasts as compared
to NSC. By contrast, SC osteoblasts expressed less OPG than
those from NSC areas. Compressions induced the expression of
genes coding for IL-6, IL-8, COX-2, IGF-1, VEGF and RANKL but
decreased the expression of OPG in NSC osteoblasts (p<0.01).
IL-6, IL-8 and PGE2 productions were also stimulated by com-
pressions. Interestingly, compressed NSC osteoblasts expressed
similar levels of these genes than SC osteoblasts, suggesting that
mechanical strains could be responsible for SC phenotype.
Conclusions: These results indicate that in response to com-
pression NSC osteoblasts expressed a phenotype similar to that
of SC osteoblasts. Moreover, SC osteoblasts are less sensitive
to mechanical stimuli than NSC osteoblasts. These results clarify
the role of compression in the pathogenesis of subchondral bone
sclerosis and allow new perspectives of research in this ﬁeld.
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Purpose: Bone tissues are remodeled through cycling of bone re-
sorption and new bone formation that are dependent by the activity
of osteoblasts and osteoclasts. Subchondral bone remodelling in
osteoarthritis (OA) and rheumatoid arthritis (RA) is mainly charac-
terized by the formation of osteophytes/ﬁbrosis and by the pres-
ence of inﬁltrating cells associated to bone resorption. In this study
we analysed on subchondral bone of OA and RA patients both
the expression of CCL20 chemokine and its receptor CCR6 on
osteoblasts, osteoclasts, osteocytes and inﬁltrating mononuclear
cells. Then we analysed its effects on osteoblasts and osteoclasts.
Methods: CCL20 and CCR6 expression was evaluated in sub-
chondral bone tissue biopsies by immunohistochemical techniques
and the percentage of positive cells was manually counted. Func-
tional assays (cell proliferation, matrix proteins expression, apop-
totic markers, signalling factor and osteoclast differentiation) on
osteoblasts and osteoclasts were performed to assess the func-
tional role of CCL20.
Results: CCL20 was positive on osteoblasts (60%) and osteo-
cytes (20%) from RA patients, while it was expressed only in
OA osteoblasts located in area of new bone formation. Both in
OA and RA biopsies, osteoclasts were highly positive to CCL20
while mononuclear cells were 10% positive in OA and 60% in
RA. The percentage of osteoblasts positive to CCR6 was not
different in OA versus RA biopsies, while the percentage of os-
teocytes and mononuclear cells positive to CCR6 was signiﬁcantly
higher in RA compared to OA. CCL20 did not affected both
the expression of different matrix proteins (i.e. bone sialopro-
tein, collagen type I, osteopontin and osteocalcin) and apoptotic
markers (like caspases 3 and 8) in OA and RA osteoblasts.
CCL20-stimulated OA osteoblasts showed a signiﬁcant increase
in β-N-acetylhexosaminidase release compared to RA while os-
teoblasts proliferation was higher only in CCL20-stimulated RA
osteoblasts associated to Akt phosphorylation. IL1β and TNFα
differently modulated CCL20, RANKL/OPG expression in OA and
RA osteoblasts. Moreover, we found that CCL20 was an early
inducer (at day3) of cell fusion events, osteoclasts differentiation
and MMP-9 release.
Conclusions: This study demonstrates a different expression of
CCL20 positive osteoblasts in OA versus RA disease that seems
to be associated with the presence of inﬁltrating mononuclear
cells. Moreover, the contemporary action of CCL20 on osteoblasts
and osteoclasts that resulted in a greater proliferative response
in RA osteoblasts compared to OA and an increased enzymatic
activity in OA osteoblasts, clearly suggests a differential role of
this chemokine in OA and RA.
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Purpose: To elucidate the expression and function of nuclear
receptor retinoid-related orphan receptor alpha1 (RORalpha1) in
human MG-63 osteoblast-like cells.
